FORMES POLYMORPHES, CRISTALLINES ET EN MESOPHASE, DU 2-(5-BROMO-4-(4-CYCLOPROPYLNAPHTALENE-1-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO) ACETATE DE SODIUM, ET UTILISATIONS CORRESPONDANTES
Crystalline polymorphs and solid mesophase forms of sodium 2-(5-bromo-4- (4-cyclopropylnaphthalen-l-yl)-4H-l,2,4-triazol-3-ylthio)acetate are described. In addition, pharmaceutical compositions and uses of such compositions for the treatment of a variety of diseases and conditions are provided.